Stocks Health care VASO
OTC · Health careVASO Corp (VASO)
VASO Corp brought in $80.2M of revenue over the twelve months to June 30, 2026, down 8.0% from a year earlier. Net income was $2.5M, a net margin of 3.1%. At June 30, 2026 it held $38.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch VASO in 60 secondsWhat VASO Corp does
VASO Corp is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on OTC under the ticker VASO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $89.1M | $1.6M | $0.01 | n/a |
| 2024 | $86.8M | $951K | $0.01 | n/a |
| 2023 | $81M | $4.8M | $0.03 | n/a |
| 2022 | $79.3M | $11.3M | $0.06 | $13.9M |
| 2021 | $75.6M | $6.1M | $0.03 | $7.4M |
| 2020 | $69.9M | $358K | $0.00 | $4.9M |
Full financial statements: income, balance sheet and cash flow
Where VASO ranks in Health care
Latest SEC filings
What VASO Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 44% to $11.2M versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- August 6, 2026Exhibits 8-K/A
- July 31, 2026
- July 23, 2026
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 0.5% to $19.4M versus the same quarter last year; diluted EPS -$0.01 versus -$0.01.
- May 8, 2026
- April 16, 2026Activist stake (5% or more) SCHEDULE 13D
- April 10, 2026Activist stake (5% or more) SCHEDULE 13D
- March 31, 2026Annual report 10-K · period to December 31, 2025Revenue rose 2.7% to $89.1M versus the prior year; diluted EPS $0.01 versus $0.01.
- February 12, 2026
Who owns VASO
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Joshua Markowitz13D, may seek influence with 1 related filers | 31.9% | April 10, 2026 |
| Jun Ma13D, may seek influence | 6% | April 16, 2026 |
Largest institutional holders
Insiders
Questions about VASO
What does VASO Corp do?
VASO Corp is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on OTC under the ticker VASO.
Is VASO Corp profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $2.5M on revenue of $80.2M, a net margin of 3.1%.
How much revenue does VASO Corp make?
Over the twelve months to June 30, 2026 VASO Corp reported revenue of $80.2M. That is 8.0% less than a year earlier.
When did VASO Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
Similar companies
Compare VASO with
Follow VASO
Get an email when VASO Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow VASO: get an email when it filesWhere the numbers come from
Financial figures are the values VASO Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.